Literature DB >> 21495263

Impact of hyperlipidaemia on the orbital bone cefotaxime levels in rats.

G Panitsa, A Panitsas, A Potamianou, J Messari, J Vovou, C Tesseromatis.   

Abstract

Facial injuries are critical conditions, leading to serious complications, such as occult facial infections. Infectious endophthalmitis occurs despite of antibiotics use during implantation of intraocular lenses and is generally resistant to antibiotic therapy. It is a crucial situation in ophthalmology, since it often induces a substantial reduction of visual acuity and in some cases the loss of the eye despite treatment. It is, therefore, important to obtain drug levels able to exert antimicrobial effect in the diseased organ. The distribution of a drug depends on the binding extent to both plasma proteins and tissues and only the free drug is capable to be transported/diffused across membranes from blood vessels into tissues, in order to achieve its effect on the target organ. Hyperlipidaemia and consequent enhanced concentration of free fatty acid can modify binding pharmacokinetics of antibiotics through antagonism for the same binding sites. Cefotaxime, the third generation cephalosporin with easy penetration in a variety of tissues and body fluids and low incidence of adverse effects, can obtain adequate concentration in blood, eye bulb, and in the orbital bones. Its levels are influenced by hyperlipidaemia with clinical impact.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21495263     DOI: 10.1007/s13318-010-0004-y

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  29 in total

1.  Danaparoid: an antithrombotic agent without major impact on triglyceride hydrolysis capacity in humans.

Authors:  H H van Barlingen; A van Beek; D W Erkelens; T W de Bruin
Journal:  J Intern Med       Date:  1997-08       Impact factor: 8.989

2.  The effects of heparin on rifampin activity against Staphylococcus epidermidis biofilms.

Authors:  R F Gagnon; A D Harris; J Prentis; G K Richards
Journal:  Adv Perit Dial       Date:  1989

3.  Alterations in cefalosporin levels in the serum and mandible of hyperlipaedemic rats after co-administration of ibuprofen.

Authors:  E Tsivou; I Melakopoulos; A Kotsiou; S Anagnostopoulou; C Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jul-Sep       Impact factor: 2.441

4.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

5.  Impact of experimental trauma and niflumic acid administration on antimicrobials' concentration in serum and mandible of rats.

Authors:  A Kotsiou; M Anagnostou; C Mourouzis; G Rallis; Ch Chantzi; C Tesseromatis
Journal:  J Musculoskelet Neuronal Interact       Date:  2006 Jul-Sep       Impact factor: 2.041

6.  Effects of experimental ocular inflammation on ocular immune privilege.

Authors:  K Ohta; B Wiggert; A W Taylor; J W Streilein
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-08       Impact factor: 4.799

7.  Free fatty acids/triglycerides increase ocular and subcutaneous blood flow.

Authors:  K Polak; L Schmetterer; A Luksch; S Gruber; E Polska; V Peternell; M Bayerle-Eder; M Wolzt; M Krebs; M Roden
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-01       Impact factor: 3.619

8.  Impact of slime dispersants and anti-adhesives on in vitro biofilm formation of Staphylococcus epidermidis on intraocular lenses and on antibiotic activities.

Authors:  Ashraf A Kadry; Soliman I Fouda; Atef M Shibl; Ahmed A Abu El-Asrar
Journal:  J Antimicrob Chemother       Date:  2009-01-14       Impact factor: 5.790

9.  Cold swimming stress: effects on serum lipids, lipoproteins and LCAT activity in male and female rats.

Authors:  C Tsopanakis; C Tesserommatis
Journal:  Pharmacol Biochem Behav       Date:  1991-04       Impact factor: 3.533

10.  Melittin interaction with sulfated cell surface sugars.

Authors:  Gabriela Klocek; Joachim Seelig
Journal:  Biochemistry       Date:  2008-01-26       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.